Home Food & Beverages Vitamin K2 Market Size, Share, Demand & Growth Forecast by 2033

Vitamin K2 Market Size & Outlook, 2025-2033

Vitamin K2 Market Size, Share & Trends Analysis Report By Product (MK-7, MK-4), By Dosage Form (Capsules/Tablets, Softgels, Liquid, Others), By Source (Natural, Synthetic), By Indication (Bone Health, Heart Health, Blood Clotting, Others), By Application (Health Supplements, Functional Foods and Beverages), By Distribution Channel (Offline, Online) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRFB57598DR
Last Updated : Sep, 2025
Pages : 110
Author : Anantika Sharma
Format : PDF, Excel

Vitamin K2 Market Overview

The global vitamin K2 market size was valued at USD 272.43 million in 2024 and is estimated to grow from USD 306.48 million in 2025 to reach USD 805.87 million by 2033, growing at a CAGR of 12.93% during the forecast period (2025–2033). Key market drivers include increasing consumer awareness of bone and cardiovascular health, rising prevalence of osteoporosis and heart diseases, growing demand for dietary supplements, and expanding use of K2 in functional foods and preventive healthcare products.

Key Market Trends & Insights

  • North America held the largest market share, over 35% of the global market.
  • Based on Product, the MK-4 segment is expected to witness the fastest CAGR of 11.45%.
  • Based on Dosage Form, the capsules/tablets segment held the highest market share of over 40%.
  • Based on Source, the natural segment is expected to witness the fastest CAGR of 13.46%.
  • Based on Indication, the bone health segment held the highest market share of over 35%.
  • Based on Application, the functional foods & beverages segment is expected to witness the fastest CAGR of 12.42%.
  • Based on Distribution Channel, the online segment is expected to witness the fastest CAGR of 13.86%.

Market Size & Forecast

  • 2024 Market Size: USD 272.43 million
  • 2033 Projected Market Size: USD 805.87 million
  • CAGR (2025-2033): 12.93%
  • Largest market in 2024: North America
  • Fastest-growing region: Asia-Pacific

Vitamin K2 is a fat-soluble vitamin that plays a crucial role in calcium metabolism, supporting bone mineralization and cardiovascular health. It activates proteins that help direct calcium to bones and teeth while preventing its accumulation in arteries. K2 is commonly used in dietary supplements, functional foods, and fortified beverages. Its applications span preventive healthcare, sports nutrition, and elderly care, helping maintain skeletal strength, improve arterial flexibility, and enhance overall wellness.

The market is driven by increasing demand for natural and plant-based supplements, expanding functional food applications, and rising interest in preventive and holistic healthcare solutions. Opportunities exist in developing innovative delivery formats, such as gummies, softgels, and fortified beverages, as well as targeting emerging markets with growing health-conscious populations. Moreover, advancements in production technologies and bioavailability enhancements create potential for wider adoption in nutraceuticals and personalized solutions.

Market Trend

Growing Consumer Awareness of Bone and Cardiovascular Health Benefits

The global Vitamin K2 market is witnessing strong momentum as consumer awareness around bone health continues to rise. With increasing cases of osteoporosis and fractures among aging populations, more individuals are turning to supplements fortified with Vitamin K2. This trend is further supported by doctors recommending preventive nutrition solutions.

Beyond bone health, consumers are also recognizing the role of Vitamin K2 in cardiovascular wellbeing, particularly its ability to regulate calcium deposition in arteries. As research findings become widely accessible through digital platforms and healthcare campaigns, awareness is translating into growing demand for Vitamin K2 supplements and fortified food products.

Vitamin K2 Market Size

To get more insights about this report Download Free Sample Report


Market Driver

Rising Prevalence of Osteoporosis and Cardiovascular Diseases

The global market for vitamin K2 is being driven by the rising prevalence of osteoporosis and cardiovascular diseases worldwide. Aging populations, sedentary lifestyles, and poor dietary habits are increasing the risk of bone fractures and heart-related conditions, prompting greater interest in preventive nutrition.

  • A study published in 2025 highlights that about 50% of women over 50 in the U.K. will experience osteoporotic fractures in their remaining lifetime much higher than men of the same age.
  • Similarly, the 2025 “Heart Disease and Stroke Statistics” update from the American Heart Association reports that nearly 47% of adults in the U.S. have high blood pressure, a major cardiovascular risk factor.

These trends are significantly boosting demand for vitamin K2 supplements and fortified foods.

Market Restraint

Limited Consumer Awareness in Developing Markets

A key restraint for the global Vitamin K2 industry is the limited consumer awareness in developing regions. While awareness in developed countries is increasing, many consumers in emerging markets remain unfamiliar with Vitamin K2’s specific health benefits, often confusing it with more common vitamins like D or calcium. This lack of understanding reduces demand and slows adoption in dietary supplements and fortified foods. Moreover, inadequate healthcare education and restricted access to premium nutrition products in these markets continue to limit Vitamin K2’s overall market penetration.

Market Opportunity

Growing Partnerships between Supplement Brands and Pharma Companies

The global vitamin K2 market is witnessing significant opportunities driven by growing partnerships between supplement brands and pharmaceutical companies. Collaborations are increasingly focused on bridging the gap between scientific research and consumer awareness, enabling brands to highlight the health benefits of vitamin K2 more effectively.

  • For instance, in March 2025, Gnosis by Lesaffre sponsored the 7th Osteoporosis Congress in Padova, Italy, bringing together experts in nephrology, osteoporosis, and bone health to advance scientific understanding of vitamin K2.
  • Similarly, in September 2025, Balchem launched a consumer-facing marketing campaign for its K2VITAL ingredient following a successful trial partnership with the FC Bayern Women’s football team, aiming to engage consumers directly and promote bone and cardiovascular health.

These initiatives reflect a broader trend of strategic collaborations that drive both innovation and consumer education in the vitamin K2 sector.


Regional Analysis

North America dominates the global vitamin K2 market, accounting for over 35% of the total share, driven by rising health awareness and strong supplement consumption. The region benefits from well-established pharmaceutical and nutraceutical industries, with major players investing in R&D and innovative product launches. Partnerships between ingredient suppliers and supplement brands are accelerating the introduction of functional foods and fortified beverages. Moreover, regulatory support and growing consumer preference for preventive healthcare contribute to the consistent market growth, making North America a critical hub for vitamin K2 development and commercial adoption.

The United States market for vitamin K2 is a key contributor to regional dominance, propelled by strong demand for bone and cardiovascular health supplements. Companies such as NattoPharma, Kappa Bioscience, and Gnosis by Lesaffre are actively expanding their portfolios and collaborating with nutraceutical brands to launch innovative K2-based products. Strategic marketing campaigns and clinical validation studies are enhancing consumer trust, while distribution through pharmacies and online retail channels ensures widespread accessibility.

Canada’s vitamin K2 market mirrors regional trends, with a focus on preventive healthcare and dietary supplementation. Industry players like Kappa Bioscience and Gnosis by Lesaffre are engaging in partnerships with local supplement companies to introduce K2-fortified products targeting bone and heart health. Clinical studies and educational campaigns are further supporting market adoption, while e-commerce platforms expand product reach.

Asia-Pacific Market Trends

Asia-Pacific is a significantly growing region in the vitamin K2 market, fueled by increasing health consciousness, rising disposable incomes, and expanding urban populations. The region shows strong demand for functional foods, dietary supplements, and fortified beverages. Companies are investing in local manufacturing and strategic partnerships to enhance product availability and awareness. Rapid adoption of preventive healthcare measures, along with expanding e-commerce channels, is driving market penetration. Asia-Pacific’s growing middle-class population and emphasis on wellness are making it a key area of opportunity for vitamin K2 industry expansion.

China’s vitamin K2 industry is witnessing robust growth, driven by rising health awareness and demand for bone and cardiovascular supplements. Companies such as NattoPharma, Gnosis by Lesaffre, and Kappa Bioscience are actively collaborating with domestic nutraceutical brands to launch K2-fortified products. Marketing campaigns, clinical trials, and digital sales channels are increasing consumer engagement, while regulatory support encourages innovation. Strong urban demand and proactive industry strategies make China a critical market.

India’s vitamin K2 market is expanding rapidly due to growing preventive healthcare awareness and increased supplement adoption. Industry leaders like Gnosis by Lesaffre and NattoPharma are partnering with local nutrition and wellness brands to introduce K2-enriched products targeting bone and heart health. Moreover, major initiatives such as clinical validation studies, social media campaigns, and online retail expansion are enhancing market visibility.


Product Insights

MK-7 is the dominant product segment in the global vitamin K2 industry due to its longer half-life and higher bioavailability compared to MK-4. This allows for more efficient absorption and prolonged circulation in the body, making it especially effective for bone and cardiovascular health. Consumer preference for MK-7 is rising as scientific studies highlight its superior role in calcium metabolism, supporting bone strength and arterial health. Its inclusion in capsules, tablets, and fortified foods is increasing globally.

Dosage Form Insights

Capsules and tablets dominate the vitamin K2 industry, holding the largest market share of over 40%, due to convenience, precise dosing, and long shelf life. These forms are widely accepted among consumers of dietary supplements and are easier to distribute through pharmacies and health stores. Capsules and tablets also allow manufacturers to combine Vitamin K2 with complementary nutrients like Vitamin D and calcium, enhancing effectiveness. Their established presence in both retail and clinical settings reinforces their leading role in the market.

Source Insights

Synthetic Vitamin K2 is the dominant source segment, largely because it is cost-effective and ensures consistent potency and purity. Unlike natural sources, which may vary in concentration, synthetic production allows large-scale manufacturing to meet growing global demand. This reliability is critical for supplement manufacturers and pharmaceutical companies, especially in developing products for bone and cardiovascular health. As awareness of Vitamin K2 benefits rises, synthetic forms are increasingly preferred for inclusion in fortified foods and standardized supplements.

Indication Insights

By indication, bone health leads the market, holding the largest share of over 35%, as the nutrient plays a crucial role in calcium regulation and bone mineralization. With rising osteoporosis prevalence, especially among postmenopausal women and the aging population, Vitamin K2 supplementation has become a preventive necessity. Clinical studies demonstrate its effectiveness in reducing fracture risk and improving bone density. Consequently, bone health-focused supplements account for the majority of Vitamin K2 sales globally, reinforcing its dominant role in therapeutic and preventive nutrition markets.

Application Insights

Health supplements lead the market, whereas functional foods & beverages are expected to record the highest CAGR of 12.42% by application, as consumers increasingly turn to preventive nutrition. Supplements provide a convenient, controlled way to meet daily Vitamin K2 requirements, particularly for bone and cardiovascular health. Their popularity is driven by awareness campaigns, scientific backing, and availability through pharmacies and retail stores. Moreover, health supplements allow combination with other nutrients like calcium and Vitamin D, enhancing their effectiveness and reinforcing their dominance over functional foods and beverages.

Distribution Channel Insights

Offline distribution dominates the market due to established retail infrastructure, including pharmacies, health stores, and supermarkets. Many consumers prefer in-person purchases for trust, product authenticity, and guidance from pharmacists. Moreover, offline channels facilitate bulk purchases and enable sampling or educational promotions, boosting consumer confidence. While online sales are growing, offline channels remain critical for reaching a broad demographic, particularly in regions where e-commerce penetration is limited or consumers favor traditional retail experiences for health supplements.


Company Market Share

Companies are investing in high-quality K2 ingredient production, clinical studies, and functional product development to meet growing consumer demand. Distribution expansion through retail, e-commerce, and nutraceutical partnerships is a priority, while marketing campaigns educate consumers on health benefits. Continuous efforts in product differentiation, formulation expertise, and regional outreach are enabling companies to secure a significant share in the evolving vitamin K2 market.

NOW Foods, established in 1968, has cemented its position as a leading global nutraceutical company. Renowned for high-quality dietary supplements, including vitamin K2, the company emphasizes rigorous testing, transparency, and science-backed formulations. Its extensive distribution network spans retail, online platforms, and international markets, ensuring broad consumer access. Continuous product innovation, partnerships with health brands, and strong consumer trust reinforce its market leadership.

  • In May 2025, NOW Foods launched its latest consumer advertising campaign titled “It’s A Healthy Obsession.” This campaign highlights the company's commitment to quality by showcasing its extensive in-house testing processes, which now include 31,000 quality tests per month. The initiative emphasizes the tagline “Quality Obsessed.

List of key players in Vitamin K2 Market

  1. NOW Foods
  2. Life Extension
  3. Pharmavite (Nature Made)
  4. Nestlé (Garden of Life)
  5. Bronson
  6. NatureWise
  7. Solaray
  8. Natural Factors
  9. Source Naturals
  10. MaryRuth Organics
Vitamin K2 Market Share of Key Players

To get more findings about this report Download Market Share


Recent Development

  • In August 2025, Rasayanam has introduced an advanced Vitamin D3 + K2 supplement aimed at enhancing bone strength and cardiovascular health. This product combines the synergistic effects of Vitamin D3 and Vitamin K2 to support calcium absorption and arterial health. The supplement is designed to cater to individuals seeking improved bone density and heart function.

Report Scope

Report Metric Details
Market Size in 2024 USD 272.43 Million
Market Size in 2025 USD 306.48 Million
Market Size in 2033 USD 805.87 Million
CAGR 12.93% (2025-2033)
Base Year for Estimation 2024
Historical Data2021-2023
Forecast Period2025-2033
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered By Product, By Dosage Form, By Source, By Indication, By Application, By Distribution Channel, By Region.
Geographies Covered North America, Europe, APAC, Middle East and Africa, LATAM,
Countries Covered U.S., Canada, U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia,

Explore more data points, trends and opportunities Download Free Sample Report

Vitamin K2 Market Segmentations

By Product (2021-2033)

  • MK-7
  • MK-4

By Dosage Form (2021-2033)

  • Capsules/Tablets
  • Softgels
  • Liquid
  • Others

By Source (2021-2033)

  • Natural
  • Synthetic

By Indication (2021-2033)

  • Bone Health
  • Heart Health
  • Blood Clotting
  • Others

By Application (2021-2033)

  • Health Supplements
  • Functional Foods and Beverages

By Distribution Channel (2021-2033)

  • Offline
    • Pharmacies & Drug Stores
    • Hypermarkets/Supermarkets
    • Others
  • Online

By Region (2021-2033)

  • North America
  • Europe
  • APAC
  • Middle East and Africa
  • LATAM

Frequently Asked Questions (FAQs)

How big is the vitamin K2 market?
The global vitamin K2 market size was valued at USD 272.43 million in 2024 and is estimated to grow from USD 306.48 million in 2025 to reach USD 805.87 million by 2033, growing at a CAGR of 12.93% during the forecast period (2025–2033).
Rising prevalence of osteoporosis and cardiovascular diseases is anticipated to boost market growth.
North America region has the largest share of the market.
NOW Foods, Life Extension, Pharmavite (Nature Made), Nestlé (Garden of Life), Bronson, NatureWise, Solaray, Natural Factors, Source Naturals, MaryRuth Organics re the major players in the global market.
Capsules/tablets dominated the market with a share of 40% in 2024.

Anantika Sharma
Research Practice Lead

Anantika Sharma is a research practice lead with 7+ years of experience in the food & beverage and consumer products sectors. She specializes in analyzing market trends, consumer behavior, and product innovation strategies. Anantika's leadership in research ensures actionable insights that enable brands to thrive in competitive markets. Her expertise bridges data analytics with strategic foresight, empowering stakeholders to make informed, growth-oriented decisions.

Speak To Analyst

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company
Request Sample Order Report Now

We are featured on :